Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 256

Sort by

Sort Order Select

Journal Articles

Efficacy of OR21, a Novel Oral Demethylating Agent in Chronic Myeloid Leukemia

Kazuharu Kamachi, MD, Hiroshi Ureshino, MD, Nao Yoshida, MD, Yuki Kurahashi, Tatsuro Watanabe, PhD, Seiji Okada, MD PhD, Shinya Kimura, MD PhD

Blood (2019) 134 (Supplement_1): 5365.

https://doi.org/10.1182/blood-2019-125460

Published: 2019

Journal Articles

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Stefano Barco, Stefanie Sollfrank, Alice Trinchero, Luigi Tomao, Barbara Zieger, Johanna A. Kremer Hovinga, MD Prof, Laura Conti, Anke Adenäuer, Erwin Miloni, Karl J. Lackner, Heidi Rossmann, Bernhard Lammle, MD

Blood (2018) 132 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2018-99-116030

Published: 2018

Journal Articles

Disulfiram May Contribute to Apoptosis of Myeloma Cells By Reactivating of Cell Cycle Regulating Gene CDKN2A

Denisa Hrckova Drozdkova, Jan Gursky, PhD, Petra Luzna, Sabina Sevcikova, PhD, Jiri Minarik, MD PhD, Katerina Smesny Trtkova, PhD

Blood (2018) 132 (Supplement 1): 5125.

https://doi.org/10.1182/blood-2018-99-114743

Published: 2018

Journal Articles

OR21, a New Oral DNA Methyltransferase Inhibitor for Treatment of MDS and AML

Hiroshi Ureshino, MD, Tatsuro Watanabe, PhD, Yuki Kurahashi, Yuki Fukuda Kurahashi, Kaoru Tohyama, MD, Seiji Okada, MD PhD, Toshikazu Ushijima, MD PhD, Hiroshi Ureshino, MD PhD

Blood (2018) 132 (Supplement 1): 5499.

https://doi.org/10.1182/blood-2018-99-112362

Published: 2018

Journal Articles

Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients

XiaoWen Tang, MD, Honglan Qu, Dandan Guo, Ting Xu, Haiping Dai, Zheng Li, Jia Yin, Xiaopeng Tian, Danqing Guo, Yang Xu, MD PhD, Xiaming Zhu, Liyan Miao, Depei Wu, MD

Blood (2017) 130 (Supplement 1): 4827.

https://doi.org/10.1182/blood.V130.Suppl_1.4827.4827

Published: 2017

Journal Articles

Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach

Blood (2017) 130 (Supplement 1): 1679.

https://doi.org/10.1182/blood.V130.Suppl_1.1679.1679

Published: 2017

Journal Articles

Acute Deletion of Tet2 or Tet3 Transiently Dysregulate Murine Erythropoiesis

Aishwarya Swaminathan, PhD, Daniel Hidalgo, MA, Hien Nguyen, Scott Shaffer, Maria Figueroa, Jian Xu, PhD, Merav Socolovsky, MBBS, PhD

Blood (2017) 130 (Supplement 1): 11.

https://doi.org/10.1182/blood.V130.Suppl_1.11.11

Published: 2017

Journal Articles

Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy

Blood (2017) 130 (Supplement 1): 56.

https://doi.org/10.1182/blood.V130.Suppl_1.56.56

Published: 2017

Journal Articles

Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment

Blood (2016) 128 (22): 347.

https://doi.org/10.1182/blood.V128.22.347.347

Published: 2016

Journal Articles

Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

Anna Mies, Tanja Božić, Michael Kramer, Julia Franzen, Gerhard Ehninger, Martin Bornhäuser, Uwe Platzbecker, Wolfgang Wagner

Blood (2016) 128 (22): 3194.

https://doi.org/10.1182/blood.V128.22.3194.3194

Published: 2016

Journal Articles

Improved Survival for MDS/CMML Patients Treated with the Combination of Decitabine (DAC) and Arsenic Trioxide (ATO) in a Phase II Adaptive Three Arm Randomization Study: DAC Alone Vs. DAC +/- Carboplatin or ATO

Patricia L. Kropf, MD, Raji Shameem, MD, Philip A. Pancari, MD, Henry Fung, MD, Lianchun Xiao, PhD, Xuelin Huang, PhD, Woonbok Chung, PhD, Hagop M. Kantarjian, MD, Jean-Pierre J. Issa, MD

Blood (2016) 128 (22): 3170.

https://doi.org/10.1182/blood.V128.22.3170.3170

Published: 2016

Journal Articles

Platelet Alpha-Storage Pool Defect Combined with Non-Classic Delta-Storage Pool Deficiency - with a Severe Bleeding Tendency

Frauke Bergmann, MD, Kathrin Schwierczek, Stefanie Sollfrank, Andreas Czwalinna, PhD, Joseph Erkel, MD, Karl Lackner, MD, Ulrich Walter, MD, Heidi Rossmann, MD, Kerstin Jurk, PhD

Blood (2016) 128 (22): 2557.

https://doi.org/10.1182/blood.V128.22.2557.2557

Published: 2016

Journal Articles

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Runa Shrestha, MD, Ahmad Al-Attar, MD, John W Hayslip, MD, Lutz T Charles, MD, Emily Dressler, PhD, Jabbour Hossam, MD, Maryam F Zia, MD, Hayder Saeed, MD, Amit Goldberg, MD, Gregory Monohan, MD, Roger Herzig, MD, Roger A Fleischman, MD, PhD, Gerhard Hildebrandt, MD, Shams A Shakil, MD, PhD

Blood (2016) 128 (22): 5296.

https://doi.org/10.1182/blood.V128.22.5296.5296

Published: 2016

Journal Articles

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Elizabeth Michelle Margolskee, MD MPH, Spencer Krichevsky, Attilio Orazi, MD, Richard T. Silver, MD

Blood (2016) 128 (22): 5471.

https://doi.org/10.1182/blood.V128.22.5471.5471

Published: 2016

Journal Articles

Resistance to Azacitidine Is Determined at Cellular Level By Lower Expression of Nucleoside Metabolizing Enzymes

Erico Masala, Ana Belén Valencia, Alessandro Sanna, MD, Alice Brogi, Laila Zaroili, Valeria Santini, MD

Blood (2016) 128 (22): 5129.

https://doi.org/10.1182/blood.V128.22.5129.5129

Published: 2016

Journal Articles

The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy

Timothy M Barrow, PhD, Laura Woodhouse, PhD, Gesa Junge, PhD, Susan J Tudhope, PhD, Charlotte Behardien, BSc, Jonathan P Wallis, MD, Helen J Marr, MD PhD, Scott R Marshall, MD, Nick Bown, PhD, Elaine Willmore, BSc, PhD, Gordon Strathdee, BSc, PhD

Blood (2016) 128 (22): 3924.

https://doi.org/10.1182/blood.V128.22.3924.3924

Published: 2016

Journal Articles

Long Non-Coding RNAs Annotation and Their Involvement in Multiple Myeloma

Arantxa Carrasco, Teresa Ezponda, Cem Meydan, PhD, Marta Kulis, Raquel Ordoñez, Leire Garate, Victor Segura, PhD, Diego Alignani, Bruno Paiva, PhD, Jesus San Miguel, MD PhD, José I. Martin Subero, PhD, Ari Melnick, MD, Felipe Prosper, MD, Xabier Agirre, PhD

Blood (2016) 128 (22): 4420.

https://doi.org/10.1182/blood.V128.22.4420.4420

Published: 2016

Journal Articles

Clonal Evolution of Gene Mutations in AML Transformation from Patients with De Novo Myelodysplastic Syndromes Carrying Spliceosome Mutations: An Analysis of 71 Paired Samples

Ming-Chung Kuo, MD, Po-Nan Wang, MD, Po Dunn, MD, Tung-Liang Lin, MD, Jin-Hou Wu, MD, Tzung-Chih Tang, MD, Yi-Jung Wu, MS, Tung-Huei Lin, MS, Chia-Hui Chang, BS, Ting-Yu Huang, MS, Che-Wei Ou, MD, Der-Cherng Liang, MD, Lee-Yung Shih, MD

Blood (2016) 128 (22): 1969.

https://doi.org/10.1182/blood.V128.22.1969.1969

Published: 2016

Journal Articles

Impact of Distinct Genetic and Epigenetic Aberrations on Survival and Response in Acute Myeloid Leukemia Patients Receiving Epigenetic Therapy

Jan K. Hiller, MD, Claudia Schmoor, Verena I. Gaidzik, MD, Charlotte Schmidt-Salzmann, MD, Arzu Yalcin, PhD, Mahmoud Abdelkarim, Nadja Blagitko-Dorfs, PhD, Konstanze Döhner, MD, Lars Bullinger, MD, Justus Duyster, MD, Michael Lübbert, MD, Björn Hackanson

Blood (2016) 128 (22): 2839.

https://doi.org/10.1182/blood.V128.22.2839.2839

Published: 2016

Journal Articles

NY-ESO-1 Vaccination in Combination with Decitabine for Patients with MDS Induces CD4+ and CD8+ T-Cell Responses

Pragya Srivastava, PhD, Junko Matsuzaki, PhD, Benjamin E. Paluch, Zachary Brumberger, Stephanie Kaufman, Adam R. Karpf, PhD, Kunle Odunsi, MDPhD, Austin Miller, PhD, Justin Kocent, Eunice S. Wang, MD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2015) 126 (23): 2873.

https://doi.org/10.1182/blood.V126.23.2873.2873

Published: 2015

NARROW

Efficacy of OR21, a Novel Oral Demethylating Agent in Chronic Myeloid Leukemia

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Disulfiram May Contribute to Apoptosis of Myeloma Cells By Reactivating of Cell Cycle Regulating Gene CDKN2A

OR21, a New Oral DNA Methyltransferase Inhibitor for Treatment of MDS and AML

Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients

Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach

Acute Deletion of Tet2 or Tet3 Transiently Dysregulate Murine Erythropoiesis

Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy

Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment

Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

Improved Survival for MDS/CMML Patients Treated with the Combination of Decitabine (DAC) and Arsenic Trioxide (ATO) in a Phase II Adaptive Three Arm Randomization Study: DAC Alone Vs. DAC +/- Carboplatin or ATO

Platelet Alpha-Storage Pool Defect Combined with Non-Classic Delta-Storage Pool Deficiency - with a Severe Bleeding Tendency

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Resistance to Azacitidine Is Determined at Cellular Level By Lower Expression of Nucleoside Metabolizing Enzymes

The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy

Long Non-Coding RNAs Annotation and Their Involvement in Multiple Myeloma

Clonal Evolution of Gene Mutations in AML Transformation from Patients with De Novo Myelodysplastic Syndromes Carrying Spliceosome Mutations: An Analysis of 71 Paired Samples

Impact of Distinct Genetic and Epigenetic Aberrations on Survival and Response in Acute Myeloid Leukemia Patients Receiving Epigenetic Therapy

NY-ESO-1 Vaccination in Combination with Decitabine for Patients with MDS Induces CD4+ and CD8+ T-Cell Responses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only